These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 39411409)

  • 1. Medication Dosing for Children With Overweight and Obesity.
    Matson KL; Horton ER; Capino AC
    J Pediatr Pharmacol Ther; 2024 Oct; 29(5):550-553. PubMed ID: 39411409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication Dosage in Overweight and Obese Children.
    Matson KL; Horton ER; Capino AC;
    J Pediatr Pharmacol Ther; 2017; 22(1):81-83. PubMed ID: 28337087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inconsistencies in dosage practice in children with overweight or obesity: A retrospective cohort study.
    Gade C; Christensen HR; Dalhoff KP; Holm JC; Holst H
    Pharmacol Res Perspect; 2018 Jun; 6(3):e00398. PubMed ID: 29721323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective description of anesthetic medication dosing in overweight and obese children.
    Burke CN; Voepel-Lewis T; Wagner D; Lau I; Baldock A; Malviya S; Nafiu O
    Paediatr Anaesth; 2014 Aug; 24(8):857-62. PubMed ID: 24708463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
    Kendrick JG; Carr RR; Ensom MH
    Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing.
    Natale S; Bradley J; Nguyen WH; Tran T; Ny P; La K; Vivian E; Le J
    Pharmacotherapy; 2017 Mar; 37(3):361-378. PubMed ID: 28079262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of drugs in obesity. An update.
    Cheymol G
    Clin Pharmacokinet; 1993 Aug; 25(2):103-14. PubMed ID: 8403734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Dosing and Pharmacokinetics in Children With Obesity: A Systematic Review.
    Harskamp-van Ginkel MW; Hill KD; Becker KC; Testoni D; Cohen-Wolkowiez M; Gonzalez D; Barrett JS; Benjamin DK; Siegel DA; Banks P; Watt KM;
    JAMA Pediatr; 2015 Jul; 169(7):678-85. PubMed ID: 25961828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1-18 Years.
    Smit C; Goulooze SC; Brüggemann RJM; Sherwin CM; Knibbe CAJ
    AAPS J; 2021 Apr; 23(3):53. PubMed ID: 33839974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children.
    Lim SY; Woo S; Miller JL; Skrepnek GH; Henry ED; Johnson PN
    Pediatr Crit Care Med; 2019 Dec; 20(12):e556-e564. PubMed ID: 31568259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and drug dosing in obese children.
    Kendrick JG; Carr RR; Ensom MH
    J Pediatr Pharmacol Ther; 2010 Apr; 15(2):94-109. PubMed ID: 22477800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal dosing of enoxaparin in overweight and obese children.
    Derbalah A; Duffull S; Sherwin CM; Job K; Al-Sallami H
    Br J Clin Pharmacol; 2022 Dec; 88(12):5348-5358. PubMed ID: 35816401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin dosing in healthy-weight, overweight, and obese pediatric patients.
    Eiland LS; Sonawane KB
    J Pediatr Pharmacol Ther; 2014 Jul; 19(3):182-8. PubMed ID: 25309148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication Errors in Overweight and Obese Pediatric Patients: A Narrative Review.
    Procaccini D; Kim JM; Lobner K; Rowcliffe M; Mollenkopf N
    Jt Comm J Qual Patient Saf; 2022 Mar; 48(3):154-164. PubMed ID: 35045950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing Pharmacokinetics in Children With Obesity-Physiological, Drug, Patient, and Methodological Considerations.
    Gerhart JG; Balevic S; Sinha J; Perrin EM; Wang J; Edginton AN; Gonzalez D
    Front Pharmacol; 2022; 13():818726. PubMed ID: 35359853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations for Intravenous Anesthesia Dose in Obese Children: Understanding PKPD.
    Morse JD; Cortinez LI; Anderson BJ
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation.
    Langebrake C; Bernhardt F; Baehr M; Kröger N; Zander AR
    Int J Clin Pharm; 2011 Dec; 33(6):918-24. PubMed ID: 21960151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of recommendations for dosing of commonly prescribed medications in critically ill obese children.
    Ross EL; Heizer J; Mixon MA; Jorgensen J; Valdez CA; Czaja AS; Reiter PD
    Am J Health Syst Pharm; 2015 Apr; 72(7):542-56. PubMed ID: 25788508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.